期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; ()
Hypokinetic dysarthria (HD) is a difficult-to-treat symptom affecting quality of life in patients with Parkinson's disease (PD). Levodopa may partiall......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (11)
Continuous subcutaneous apomorphine infusion (CSAI) is used to treat patients with Parkinson's disease (PD) who are experiencing motor fluctuations. H......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (12)
This study aimed at assessing the clinimetrics of the Montreal Cognitive Assessment (MoCA) in an Italian cohort of patients with adult-onset idiopathi......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (9)
The early postnatal period represents an exceptionally vulnerable phase for the development of neurobiological alterations, aberrant behavior, and psy......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (10)
Cognitive impairment (CI), previously considered as a non-supporting feature of multiple system atrophy (MSA), according to the second consensus crite......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (3)
Intellectual disability with or without manifestations of autism and/or epilepsy affects 1-2% of the population, and it is estimated that more than 30......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (1)
The background of this study is to investigate whether striatal dopamine depletion patterns (selective involvement in the sensorimotor striatum or asy......
期刊： JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (2)
Neutropenia and agranulocytosis (N&A) are relatively rare, but potentially fatal adverse drug reactions (ADR). This study presents cases of N&......
